Synageva Biopharma (GEVA) Posts Q3 Loss of $1.02/Share
Tweet Send to a Friend
Synageva Biopharma (Nasdaq: GEVA) reported Q3 EPS of ($1.02), $0.13 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
